Annovis Net Debt from 2010 to 2024

ANVS Stock

USD 6.54 0.02 0.30%

Annovis Bio Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt will likely drop to about -6 M in 2024. Net Debt is the total debt of Annovis Bio minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2018-12-31

Previous Quarter

-4 M

Current Value

-12.6 M

Quarterly Volatility

17 M

Covid

Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 6.6 B or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.

Check out the analysis of Annovis Bio Correlation against competitors.

For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Net Debt Growth Pattern

Below is the plot of the Net Debt of Annovis Bio over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Annovis Bio's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Annovis Net Debt Regression Statistics

	Arithmetic Mean	(6,416,845)
	Geometric Mean	1,020,718
	Coefficient Of Variation	(204.51)
	Mean Deviation	8,385,044
	Median	(347,472)
	Standard Deviation	13,122,799
	Sample Variance	172.2T
	Range	46.2M
	R-Value	(0.51)
	Mean Square Error	138.1T
	R-Squared	0.26
	Significance	0.05
	Slope	(1,482,115)
	Total Sum of Squares	2410.9T

Annovis Net Debt History

	2024	-6 M
	2023	-5.8 M
	2022	-28.4 M
	2021	-45.7 M
	2020	-8.1 M
	2019	497.9 K
	2018	-35.3 K

Other Fundumenentals of Annovis Bio

Net Debt To E B I T D A

Annovis Bio Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt	Long Term Debt Total	Deferred Long Term Liab
Total Assets		0.92	0.75	-0.36	0.52	0.21	-0.04	0.99	0.12	-0.15	0.23	-0.15	-0.92	0.7	0.89	0.92	0.67	-0.1	-0.1	-0.1
Total Stockholder Equity	0.92		0.5	-0.03	0.41	0.21	-0.42	0.91	0.24	0.0	0.21	0.02	-0.9	0.43	0.93	0.9	0.49	0.23	0.23	0.23
Net Tangible Assets	0.75	0.5		-0.88	0.34	-0.05	0.45	0.76	-0.24	-0.12	-0.03	-0.21	-0.66	0.98	0.54	0.67	0.9	-0.66	-0.66	-0.66
Retained Earnings	-0.36	-0.03	-0.88		-0.18	0.15	-0.75	-0.37	0.43	0.2	0.15	0.32	0.27	-0.89	-0.12	-0.28	-0.78	0.87	0.87	0.87
Accounts Payable	0.52	0.41	0.34	-0.18		0.82	0.19	0.41	0.69	-0.13	0.85	-0.16	-0.17	0.21	0.16	0.17	0.17	-0.06	-0.06	-0.06
Net Receivables	0.21	0.21	-0.05	0.15	0.82		-0.03	0.09	0.81	-0.2	0.98	-0.22	0.12	-0.19	-0.11	-0.12	-0.19	0.12	0.12	0.12
Total Liab	-0.04	-0.42	0.45	-0.75	0.19	-0.03		-0.04	-0.32	-0.37	0.01	-0.45	0.17	0.5	-0.32	-0.16	0.32	-0.78	-0.78	-0.78
Total Current Assets	0.99	0.91	0.76	-0.37	0.41	0.09	-0.04		0.0	-0.17	0.1	-0.17	-0.96	0.73	0.93	0.96	0.71	-0.09	-0.09	-0.09
Intangible Assets	0.12	0.24	-0.24	0.43	0.69	0.81	-0.32	0.0		0.35	0.87	0.36	0.16	-0.39	-0.1	-0.16	-0.38	0.34	0.34	0.34
Common Stock	-0.15	0.0	-0.12	0.2	-0.13	-0.2	-0.37	-0.17	0.35		-0.11	0.98	0.14	-0.18	-0.12	-0.14	-0.2	0.11	0.11	0.11
Property Plant Equipment	0.23	0.21	-0.03	0.15	0.85	0.98	0.01	0.1	0.87	-0.11		-0.13	0.12	-0.17	-0.1	-0.12	-0.18	0.11	0.11	0.11
Good Will	-0.15	0.02	-0.21	0.32	-0.16	-0.22	-0.45	-0.17	0.36	0.98	-0.13		0.12	-0.26	-0.09	-0.12	-0.29	0.18	0.18	0.18
Net Debt	-0.92	-0.9	-0.66	0.27	-0.17	0.12	0.17	-0.96	0.16	0.14	0.12	0.12		-0.67	-0.98	-1.0	-0.68	-0.01	-0.01	-0.01
Capital Surpluse	0.7	0.43	0.98	-0.89	0.21	-0.19	0.5	0.73	-0.39	-0.18	-0.17	-0.26	-0.67		0.54	0.68	0.92	-0.68	-0.68	-0.68
Net Invested Capital	0.89	0.93	0.54	-0.12	0.16	-0.11	-0.32	0.93	-0.1	-0.12	-0.1	-0.09	-0.98	0.54		0.98	0.6	0.17	0.17	0.17
Net Working Capital	0.92	0.9	0.67	-0.28	0.17	-0.12	-0.16	0.96	-0.16	-0.14	-0.12	-0.12	-1.0	0.68	0.98		0.69	0.01	0.01	0.01
Capital Stock	0.67	0.49	0.9	-0.78	0.17	-0.19	0.32	0.71	-0.38	-0.2	-0.18	-0.29	-0.68	0.92	0.6	0.69		-0.48	-0.48	-0.48
Long Term Debt	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48		1.0	1.0
Long Term Debt Total	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48	1.0		1.0
Deferred Long Term Liab	-0.1	0.23	-0.66	0.87	-0.06	0.12	-0.78	-0.09	0.34	0.11	0.11	0.18	-0.01	-0.68	0.17	0.01	-0.48	1.0	1.0

Click cells to compare fundamentals

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-5.8 M	-6 M
Net Debt To EBITDA	0.13	0.12

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Annovis Net Debt from 2010 to 2024

Latest Annovis Bio's Net Debt Growth Pattern

Annovis Net Debt Regression Statistics

Annovis Net Debt History

Other Fundumenentals of Annovis Bio

Annovis Bio Net Debt component correlations

About Annovis Bio Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Annovis Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY